TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

NCT07052903 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1250

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin Amyloidosis With Cardiomyopathy

Interventions

DRUG: Nucresiran
DRUG: Sterile Normal Saline (0.9% NaCl)

Sponsor

Alnylam Pharmaceuticals